Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients

Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients

Following transplantation, patients must take immunosuppressive medication for life. Torquetenovirus (TTV) is thought to be marker for immunosuppression, and TTV−DNA levels after organ transplantation have been investigated, showing high TTV levels, associated with increased risk of infect...

Full description

Bibliographic Details
Main Authors: Edmund J. Gore, António W. Gomes-Neto, Lei Wang, Stephan J. L. Bakker, Hubert G. M. Niesters, Anoek A. E. de Joode, Erik A. M. Verschuuren, Johanna Westra, Coretta Van Leer-Buter
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Journal of Clinical Medicine
Subjects:
torquetenovirus
immunosuppression
transplantation
immunosuppressed host
outcome
renal transplantation
Online Access:https://www.mdpi.com/2077-0383/9/2/440

Internet

https://www.mdpi.com/2077-0383/9/2/440

Similar Items